Serum growth factors in patients with pancreatic cancer

Tumor Biology

Volumn 20, Issue 2, 1999, Pages 65-71

  Meggiato, T ^b   Plebani, M ^b   Basso, D ^b   Panozzo, M P ^b   Del Favero, Giuseppe ^a  

^a Istituto di Medicina Interna di Padova   (Italy)

^b NONE

Author keywords

Epidermal growth factor; Growth factors; Insulin like growth factor I; Pancreatic cancer; Somatostatin

Indexed keywords

BILIRUBIN; EPIDERMAL GROWTH FACTOR; GLUCOSE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC PANCREATITIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0033026511     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030049     Document Type: Article

References (25)

1. Almoguera C, Shibata D, Forrest K, Martin J, Perucho M: Most human carcinomas of the exocrine pancreas contains mutation c-K-ras genes. Cell 1988;53:549-554.
2. Motojiama K, Urano T, Nagata Y, Shiku H, Tsunoda T, Kanematsu T: Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumour stage in human pancreatic carcinoma. Am J Gastroenterol 1991;86: 1784-1788.
3. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR: Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991; 163:111-116.
4. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Beger HG, Korc M: Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumour aggressiveness. Anticancer Res 1993;13:565-570.
5. Ohmura E, Okada N, Kamiya Y, Murakami H, Tsushima T, Shizume K: Insulin-like growth factor I and transforming growth factor a as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 1990;50:103-107.
6. Carpenter G: Epidermal growth factor. Handb Exp Pharmacol 1981;57: 90-126.
7. Denubinsky A, Gregory H, Konturek SL, Polanski M: Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol 1982;325:35-42.
8. Carpenter G, Cohen S: Human epidermal growth factor and proliferation of human fibroblast. J Cell Physiol 1976;88:227-237.
9. Logsolon CD: Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol 1986;251: G487-G494.
10. Chester JF, Gaissert HA, Ross JS, Malt RA: Pancreatic cancer in the Syrian hamster induced by N-nitrosobis(2-oxyproyl)amine: Cocarcinogenic effect of epidermal growth factor. Cancer Res 1986;46:2954-2957.
11. Chen YF, Pan GZ, Hou X: Epidermal growth factor in carcinogenesis. Cancer Res 1986;46:1030-1037.
12. Cullen KJ, Yee D, Rosen N: Insulin like growth factors in human malignancy. Cancer Invest 1991;9:443-445.
13. Ohmura E, Okada M, Onada N, et al: Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 1990;50:103-107.
14. Boden G, Sivitz MC, Owen OE: Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 1975;190:163-165.
15. Johnston DG, Davies RR, Tunner SJ: Effects of somatostatin and SMS 201-995 on carbohydrate metabolism in normal men. Scand J Gastroenterol 1986;21(suppl 119):73-83.
16. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB: All five cloned human somatatostin receptors (hSSTR 1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun 1994; 198:605-612.
17. 2+ mobilization by cloned human somatostatin receptor sb-type 1-5 in transfect COS-7 cell. FEBS Lett 1994;348:192-196.
18. Liebow C, Reilly C, Serrano M, Schally AV: Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci USA 1989; 86:2003-2007.
19. Ren S, Ezzat S, Melmed S, Braunstein GD: Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells. Endocrinology 1992;131:2470-2481.
20. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Schally AV: Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastric-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-60. Int J Cancer 1994;57:574-580.
21. Barni S, Lissoni P, Brivio F, Fumagalli L, Merlini D, Cataldo M. Rovelli F, Tancini G: Serum levels of insulin-like growth factor-I in operable breast cancer in relation to main prognostic variables and their preoperative changes in relation to those of protein. Tumori I994;80: 212-215.
22. Choen P, Peehl DM, Stamey TA, Wilson KF, Clemmons DR, Rosenfeld RG: Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab 1993;76:1031-1035.
23. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Kore M: Insulin-like growth factor I, overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-2011.
24. Chen YF, Pan GZ, Hou X, Liu TH, Chen J, Yanaihara C, Yanaihara N: Epidermal growth factor and its receptors in human pancreatic carcinoma. Pancreas 1990;5/3:278-283.
25. Reubi JC, Horisberger U, Essed CE, Jeekel J, Klijn JGH, Lamberts SWJ: Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 1988;95:760-763.